Stocks and Investing Stocks and Investing
Thu, May 16, 2024
Wed, May 15, 2024

Serge Belanger Maintained (ARQT) at Strong Buy with Increased Target to $18 on, May 15th, 2024


Published on 2024-10-28 11:24:17 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Increased Target from $16 to $18 on, May 15th, 2024.

Serge has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, all agrees with Serge's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jonathan Block of "Goldman Sachs" Maintained at Hold with Increased Target to $11 on, Wednesday, February 28th, 2024

Contributing Sources